On October 1 st , 2025, the DRAIGON consortium held its first review meeting with the European Commission (EC), a panel of external scientific experts and project partners, in hybrid format. More than 15 participants joined, representing all beneficiaries, affiliated partners, the EC project officers, and three external reviewers. This milestone marked the formal assessment of the first 18 months of progress set the direction for the next phase. During the first 18 months, th

The DRAIGON project announces the appointment of the independent Scientific and Ethics Advisory Committee (SEAC), a group comprised of...

The project goal is to create an innovative in vitro diagnostic device (IVD) to predict antimicrobial resistance in real-time.

The DRAIGON Consortium launched its website! The project's objective is to create a cutting-edge in vitro diagnostic device (IVD) that...

The ambitious project mission is to develop a novel diagnostic tool to tackle antimicrobial resistance (AMR) through the integration of...